TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28053054

Group type: EXPERIMENTAL
Intervention: Ciclosporin
Number of subjects: 115

Group type: COMPARATOR
Intervention: Infliximab
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Ciclosporin and Infliximab
Number of subjects: 115
Study: 27151007

Group type: EXPERIMENTAL
Intervention: Rituximab combined with methotrexate
Number of subjects: 58

Group type: COMPARATOR
Intervention: Methotrexate combined with whole brain radiotherapy
Number of subjects: 58
Study: 24183730

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training/behavioral therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study: 22520520

Group type: EXPERIMENTAL
Intervention: Promus Element
Number of subjects: 1788

Group type: COMPARATOR
Intervention: Resolute Integrity
Number of subjects: 1788
Study: 20589696

Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Not achieving MDA
Number of subjects: 108
Study: 17549054

Group type: EXPERIMENTAL
Intervention: Fresh frozen plasma (FFP) infusions
Number of subjects: 43

Group type: COMPARATOR
Intervention: No fresh frozen plasma (FFP) infusions
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Combined results from FFP group
Number of subjects: 43

Group type: COMPARATOR
Intervention: Combined results from no FFP group
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Overall results
Number of subjects: 43
Study: 10879067

Group type: EXPERIMENTAL
Intervention: Various treatments for atherosclerosis; specific interventions not detailed in the abstract.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable; control group not specified.
Number of subjects: 0
Study: 9075448

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering intervention (Food for Heart Program)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 372
Study: 8445289

Group type: EXPERIMENTAL
Intervention: Thromboxane synthase inhibitor (FCE 22178, 400 mg two or three times per day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 3021497

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 29174274

Group type: EXPERIMENTAL
Intervention: Placentophagy (encapsulated placenta)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 27230770

Group type: EXPERIMENTAL
Intervention: 6-month family intervention to reduce screen time
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Primary caregiver intervention use
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Intervention delivery by community workers
Number of subjects: 251
Study: 25095797

Group type: EXPERIMENTAL
Intervention: Client-centred health promotion intervention (eight telephone health promotion sessions)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Client-centred health promotion intervention
Number of subjects: 300
Study: 23579561

Group type: EXPERIMENTAL
Intervention: Reaching training in supine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Reaching training in reclined
Number of subjects: 24

Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 24
Study: 20176355

Group type: EXPERIMENTAL
Intervention: Immediate sheath removal and early ambulation (Intervention Group, n=172)
Number of subjects: 347

Group type: COMPARATOR
Intervention: Standard care with sheath removal after 4h and additional 6h of rest (Control Group, n=175)
Number of subjects: 347
Study: 17323092

Group type: EXPERIMENTAL
Intervention: Ponseti's method
Number of subjects: 45

Group type: COMPARATOR
Intervention: Kite's method
Number of subjects: 45
Study: 16356945

Group type: EXPERIMENTAL
Intervention: Practice nurse led partner notification
Number of subjects: 140

Group type: COMPARATOR
Intervention: Referral to a genitourinary medicine clinic
Number of subjects: 140
Study: 12792342

Group type: EXPERIMENTAL
Intervention: Exercise group (n = 11)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (n = 13)
Number of subjects: 24
Study: 10799728

Group type: EXPERIMENTAL
Intervention: Post-mastectomy irradiation plus systemic treatment
Number of subjects: 17

Group type: COMPARATOR
Intervention: Systemic treatment alone
Number of subjects: 17
Study: 8970246

Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2%
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Brimonidine 0.5%
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Brimonidine 0.5% (one drop preoperatively, postoperatively or both)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Brimonidine 0.2% twice daily
Number of subjects: 186

Group type: COMPARATOR
Intervention: Brimonidine 0.2% three times daily
Number of subjects: 186
Study: 1503059

Group type: EXPERIMENTAL
Intervention: Zinc-fortified formula
Number of subjects: 39

Group type: COMPARATOR
Intervention: Non-supplemented formula (Control)
Number of subjects: 39
Study: 29569405

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 334

Group type: COMPARATOR
Intervention: No Digoxin (Control)
Number of subjects: 334
Study: 27513397

Group type: EXPERIMENTAL
Intervention: Seawater (2.3%) nasal drops
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Saline (0.9%) nasal drops
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (no nasal drops)
Number of subjects: 109
Study: 25464511

Group type: EXPERIMENTAL
Intervention: Acute stress via Trier social stress test (TSST)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Baseline measurements
Number of subjects: 22
Study: 22386762

Group type: EXPERIMENTAL
Intervention: LR-Accu-Vit
Number of subjects: 242

Group type: COMPARATOR
Intervention: LR-fresh
Number of subjects: 242
Study: 19697094

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy group (IPT-G)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 50
Study: 18241525

Group type: EXPERIMENTAL
Intervention: Human thrombin
Number of subjects: 305

Group type: COMPARATOR
Intervention: Bovine thrombin
Number of subjects: 305
Study: 17242805

Group type: EXPERIMENTAL
Intervention: Nizatidine 600 mg
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 12809451

Group type: EXPERIMENTAL
Intervention: Morning insulin glargine + 3 mg glimepiride
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Bedtime insulin glargine + 3 mg glimepiride
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Bedtime NPH insulin + 3 mg glimepiride
Number of subjects: 695

Group type: COMPARATOR
Intervention: Morning insulin glargine
Number of subjects: 695

Group type: COMPARATOR
Intervention: Bedtime NPH insulin
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Bedtime insulin glargine
Number of subjects: 695
Study: 10810461

Group type: EXPERIMENTAL
Intervention: Standard treatment protocols for osteosarcoma (same as used for adolescents)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard treatment protocols for osteosarcoma
Number of subjects: 30
Study: 8861695

Group type: EXPERIMENTAL
Intervention: Loading dose of 10 mg/kg of phenytoin (group A, n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Loading dose of 15 mg/kg of phenytoin (group B, n = 10)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PHT maintenance treatment (250 mg, i.v., every 8 hours)
Number of subjects: 20
Study: 1739172

Group type: EXPERIMENTAL
Intervention: rIFN-gamma (100 micrograms) subcutaneously each day for 10 days
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: rIFN-gamma
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study: 6519156

Group type: EXPERIMENTAL
Intervention: Diphenhydramine 25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diphenhydramine 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diphenhydramine 100 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30699315

Group type: EXPERIMENTAL
Intervention: Oral antibiotics
Number of subjects: 1054

Group type: COMPARATOR
Intervention: Intravenous antibiotics
Number of subjects: 1054
Study: 30130674

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 755
Study: 27387676

Group type: EXPERIMENTAL
Intervention: Combined radiochemotherapy and tumor resection
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Solely radiochemotherapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy followed by tumor resection
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Chemotherapy only
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall event-free survival (ES)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bladder preservation rate
Number of subjects: 50
Study: 24203264

Group type: EXPERIMENTAL
Intervention: E-O technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: E-C technique
Number of subjects: 100
Study: 22124712

Group type: EXPERIMENTAL
Intervention: Melatonin administration prior to EEG recording
Number of subjects: 50

Group type: COMPARATOR
Intervention: No melatonin administration prior to EEG recording
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (with and without melatonin)
Number of subjects: 50
Study: 19247575

Group type: EXPERIMENTAL
Intervention: High-intensity exercise group (EG)
Number of subjects: 71

Group type: COMPARATOR
Intervention: No-exercise group (no-EG)
Number of subjects: 71
Study: 18727656

Group type: EXPERIMENTAL
Intervention: Lactobacillus salivarius WB21 (6.7 x 10(8) CFU) with xylitol, three times a day for 8 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (xylitol alone), three times a day for 8 weeks
Number of subjects: 66
Study: 16198658

Group type: EXPERIMENTAL
Intervention: Cyclosporine 100 mg
Number of subjects: 12
Study: 11967035

Group type: EXPERIMENTAL
Intervention: Ultrasound screening of kidneys in newborns
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Second ultrasound scanning at one month of age
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Follow-up ultrasound studies
Number of subjects: 4000
Study: 10439743

Group type: EXPERIMENTAL
Intervention: Neostigmine (0.07 mg/kg) with glycopyrrolate (0.01 mg/kg) given 5 min after relaxant
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (no neostigmine)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Succinylcholine (1.5 mg/kg)
Number of subjects: 160
Study: 7557093

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Prazosin + Propranolol
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Prazosin + Furosemide
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 2112346

Group type: EXPERIMENTAL
Intervention: Packed red blood cells (AS-1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Washed red blood cells
Number of subjects: 20
Study: 38439

Group type: EXPERIMENTAL
Intervention: Cranberry juice (amounts: 150, 180, 210, 240 ml) ingested with each meal during a 12-day period.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no cranberry juice) during the first 6 days of the study.
Number of subjects: 40
Study: 31172201

Group type: EXPERIMENTAL
Intervention: Consumption of cooked potatoes, oatmeal, corn flakes, cereals, pasta, and rice
Number of subjects: 2523

Group type: EXPERIMENTAL
Intervention: Consumption of cooked potatoes
Number of subjects: 2523

Group type: EXPERIMENTAL
Intervention: Cigarette consumption
Number of subjects: 2523

Group type: EXPERIMENTAL
Intervention: Psoriasis, allergic rhinitis, and atopic dermatitis
Number of subjects: 2523
Study: 28758155

Group type: EXPERIMENTAL
Intervention: APOL1 renal-risk variants (RRVs)
Number of subjects: 2568
Study: 25886499

Group type: EXPERIMENTAL
Intervention: Patient education + 12-week supervised exercise therapy program
Number of subjects: 45

Group type: COMPARATOR
Intervention: Patient education only
Number of subjects: 45
Study: 23692624

Group type: EXPERIMENTAL
Intervention: Nylon cuff (5 × 83 cm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Elastic cuff (5 × 135 cm)
Number of subjects: 0
Study: 21382953

Group type: EXPERIMENTAL
Intervention: Self-directed education (textbook, instructional video, portable equipment kit, 90-minute simulation)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Traditional class (6 hours of lectures and instructor-directed skill stations)
Number of subjects: 46
Study: 19594771

Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 1706

Group type: COMPARATOR
Intervention: Control (non-statin treatment)
Number of subjects: 1706
Study: 17301206

Group type: EXPERIMENTAL
Intervention: Implementation of guidelines for the management of patients with atrial fibrillation and TIA using a multifaceted approach including evidence‐based recommendations, audit and feedback, interactive educational sessions, patient prompts and outreach visits.
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Implementation of guidelines for the management of patients with atrial fibrillation and TIA.
Number of subjects: 76
Study: 15697105

Group type: EXPERIMENTAL
Intervention: 35 microg Ethinylestradiol/2 mg Cyproterone Acetate (Diane 35, Schering) for 3 months
Number of subjects: 31

Group type: COMPARATOR
Intervention: 10 mg Medroxyprogesterone Acetate (MPA) x 10 days every month for 3 months (control group)
Number of subjects: 31
Study: 12172440

Group type: EXPERIMENTAL
Intervention: Fixed-dose low molecular weight heparin (LMWH) Certoparin, 2 x 8000 aXa IU
Number of subjects: 0
Study: 9596473

Group type: EXPERIMENTAL
Intervention: Cholera vaccine 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholera vaccine 2
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unvaccinated control group
Number of subjects: 0
Study: 7577315

Group type: EXPERIMENTAL
Intervention: ACE-inhibitors
Number of subjects: 0
Study: 2539763

Group type: EXPERIMENTAL
Intervention: Quinapril (10, 20, and 40 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril (10, 20, and 40 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quinapril with hydrochlorothiazide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quinapril and Enalapril
Number of subjects: 0
Study: 81154

Group type: EXPERIMENTAL
Intervention: Ibuprofen 1200 mg daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Diclofenac 75 mg daily
Number of subjects: 30
Study: 31957686

Group type: EXPERIMENTAL
Intervention: Standard Care + Brief Motivational Intervention (SC+BMI)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Standard Care Alone (SC)
Number of subjects: 43
Study: 31058457

Group type: EXPERIMENTAL
Intervention: Self-monitoring urinary salt excretion measurement device for 4 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 28550914

Group type: EXPERIMENTAL
Intervention: Self-drilling screws (SDS)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Self-tapping screws (STS)
Number of subjects: 49
Study: 25909530

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 19
Study: 23218853

Group type: EXPERIMENTAL
Intervention: Nitroprusside gel (10 mg, 1 mL)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Nitroprusside gel
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 21787498

Group type: EXPERIMENTAL
Intervention: Resilon (RealSeal system)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Gutta‐percha (with AH Plus sealer)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Negative control group (unfilled specimens)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Positive control group (flowable, dual‐cure composite resin)
Number of subjects: 80
Study: 19458363

Group type: EXPERIMENTAL
Intervention: Early intervention (coronary angiography < or = 24 hours after randomization)
Number of subjects: 3031

Group type: COMPARATOR
Intervention: Delayed intervention (coronary angiography > or = 36 hours after randomization)
Number of subjects: 3031

Group type: EXPERIMENTAL
Intervention: Early intervention in high-risk patients
Number of subjects: 3031

Group type: EXPERIMENTAL
Intervention: Early intervention in low-to-intermediate risk patients
Number of subjects: 3031
Study: 16731317

Group type: EXPERIMENTAL
Intervention: Doppler ultrasound (SonoGuide2 with a 5.0‐MHz probe)
Number of subjects: 338

Group type: COMPARATOR
Intervention: B-mode ultrasound (SiteRite II ultrasound system with a 7.5‐MHz transducer)
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Doppler ultrasound
Number of subjects: 338

Group type: COMPARATOR
Intervention: B-mode ultrasound
Number of subjects: 338
Study: 15308353

Group type: EXPERIMENTAL
Intervention: Men D (2 doses at 3 and 9 months)
Number of subjects: 618

Group type: COMPARATOR
Intervention: Men PS (at 24 months)
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Men D (single dose in infancy)
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Men D
Number of subjects: 618

Group type: COMPARATOR
Intervention: Men PS
Number of subjects: 618
Study: 10958046

Group type: EXPERIMENTAL
Intervention: Gabapentin 1200 mg/day (400 mg/day from 1st to 3rd day, 800 mg/day from 4th to 6th day, 1200 mg/day from 7th day)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (control group not explicitly detailed)
Number of subjects: 63
Study: 8623963

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg IV ephedrine
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg IV ephedrine
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 110
Study: 1836780

Group type: EXPERIMENTAL
Intervention: Ketoconazole 2% emulsion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (same emulsion without active drug)
Number of subjects: 50
Study: 6122755

Group type: EXPERIMENTAL
Intervention: Intestinal lavage with 18 L of normal saline administered via a jejunal tube over a period of 2 hours
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group receiving similar treatment without lavage
Number of subjects: 6
Study: 31535519

Group type: EXPERIMENTAL
Intervention: Resin-based sealant
Number of subjects: 10

Group type: COMPARATOR
Intervention: Resin modified glass ionomer-based sealant
Number of subjects: 10
Study: 28822828

Group type: EXPERIMENTAL
Intervention: Spironolactone (25mg/d)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 308
Study: 26720458

Group type: EXPERIMENTAL
Intervention: Lutein (10 mg) and antioxidant supplement
Number of subjects: 79

Group type: COMPARATOR
Intervention: Lutein and antioxidant supplement in combination with PUFA
Number of subjects: 79
Study: 24617431

Group type: EXPERIMENTAL
Intervention: Methotrexate (7.5 mg weekly)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ciclosporin (2.5 mg kg(‐1) daily)
Number of subjects: 40
Study: 22068879

Group type: EXPERIMENTAL
Intervention: Attention training followed by memory training
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Memory training followed by attention training
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no cognitive training)
Number of subjects: 51
Study: 20048271

Group type: EXPERIMENTAL
Intervention: Cultural competency training and monthly race-stratified performance reports
Number of subjects: 2699
Study: 17630653

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 202
Study: 15701591

Group type: EXPERIMENTAL
Intervention: Calcipotriol/betamethasone dipropionate ointment (Daivobet/Dovobet), applied once daily for 4 weeks.
Number of subjects: 1534
Study: 11840365

Group type: COMPARATOR
Intervention: Usual hematocrit (30%-33%) with no exercise training (UH)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Usual hematocrit (30%-33%) plus exercise training (UHX)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Normalized hematocrit (40%-42%) with no exercise training (NH)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Normalized hematocrit (40%-42%) plus exercise training (NHX)
Number of subjects: 65
Study: 10520159

Group type: EXPERIMENTAL
Intervention: Complete dental restoration
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Local application of amphotericin B
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Combination of dental treatment plus amphotericin B
Number of subjects: 54

Group type: COMPARATOR
Intervention: Caries-free subjects (Control)
Number of subjects: 54
Study: 7781398

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus concurrent radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radiation alone
Number of subjects: 0
Study: 2478278

Group type: EXPERIMENTAL
Intervention: Sound and slide presentation
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Verbal demonstration
Number of subjects: 666

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 666
Study: 1080560

Group type: EXPERIMENTAL
Intervention: Gently oscillating waterbed
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Non-oscillating waterbed
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no waterbed)
Number of subjects: 21
Study: 31650315

Group type: EXPERIMENTAL
Intervention: Reciprocating single file, single cone technique
Number of subjects: 120

Group type: COMPARATOR
Intervention: Hand files and lateral compaction technique
Number of subjects: 120
Study: 31234840

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention including identification of drug related problems, drug interactions, change in dose, frequency and therapy switches, and non-pharmacological intervention consisting of diet, lifestyle and behavior counseling
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Pharmacist-led intervention
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 244
Study: 29217757

Group type: EXPERIMENTAL
Intervention: Elamipretide (0.25 mg·kg‐1·h‐1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 25195661

Group type: EXPERIMENTAL
Intervention: EndoActivator (group EA)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Endodontic irrigating needle (group EN)
Number of subjects: 72